Liang Shi

6.1k total citations · 2 hit papers
117 papers, 4.5k citations indexed

About

Liang Shi is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Liang Shi has authored 117 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 30 papers in Oncology and 30 papers in Immunology. Recurrent topics in Liang Shi's work include MicroRNA in disease regulation (14 papers), Genomics, phytochemicals, and oxidative stress (11 papers) and Drug-Induced Hepatotoxicity and Protection (11 papers). Liang Shi is often cited by papers focused on MicroRNA in disease regulation (14 papers), Genomics, phytochemicals, and oxidative stress (11 papers) and Drug-Induced Hepatotoxicity and Protection (11 papers). Liang Shi collaborates with scholars based in China, United States and Taiwan. Liang Shi's co-authors include Lili Ji, Xiujun Cai, Guobin Wang, Hui Lin, Yuping Yin, Zhengtao Wang, Kaixiong Tao, Keith A. Crutcher, Zhiyong Zheng and Kaixiong Tao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Liang Shi

115 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Maresin1 Protect Against Ferroptosis-Induced Liver Injury Through ROS Inhibition and Nrf2/HO-1/GPX4 Activation

2022 145 citations Wenchang Yang, Yaxin Wang et al. profile →
4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer

2023 124 citations Wenchang Yang, Chengguo Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liang Shi China	39	2.1k	1.0k	983	928	570	117	4.5k
Tian Lan China	38	2.3k 1.1×	892 0.9×	630 0.6×	587 0.6×	920 1.6×	134	4.5k
Qi Li China	43	3.5k 1.6×	1.7k 1.6×	667 0.7×	972 1.0×	516 0.9×	206	6.0k
Weiping Chen China	42	3.2k 1.5×	780 0.8×	660 0.7×	765 0.8×	1.1k 1.8×	191	6.5k
Chin‐Wen Chi Taiwan	38	2.0k 0.9×	841 0.8×	381 0.4×	559 0.6×	540 0.9×	77	3.7k
Sang‐Kyu Ye South Korea	38	2.3k 1.1×	1.0k 1.0×	1.1k 1.1×	1.2k 1.3×	294 0.5×	120	4.9k
Xiaoni Kong China	32	1.7k 0.8×	515 0.5×	952 1.0×	645 0.7×	1.3k 2.2×	114	4.4k
Xiao‐Kang Li Japan	38	2.1k 1.0×	409 0.4×	894 0.9×	384 0.4×	544 1.0×	190	5.1k
Bin Li China	37	2.6k 1.2×	796 0.8×	818 0.8×	498 0.5×	935 1.6×	271	5.2k
Michitaka Ozaki Japan	37	2.0k 1.0×	520 0.5×	918 0.9×	778 0.8×	819 1.4×	133	4.7k
Danny N. Dhanasekaran United States	38	3.3k 1.5×	1.2k 1.2×	609 0.6×	638 0.7×	540 0.9×	107	5.2k

Countries citing papers authored by Liang Shi

Since Specialization

Citations

This map shows the geographic impact of Liang Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Shi more than expected).

Fields of papers citing papers by Liang Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liang Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Shi. The network helps show where Liang Shi may publish in the future.

Co-authorship network of co-authors of Liang Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Liang Shi. A scholar is included among the top collaborators of Liang Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang Shi. Liang Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shen, Hao, Boqiang Liu, Weijun Zhao, et al.. (2025). Lactate Metabolic Reprogramming Mediated by CircRNA–LDHA Complex Facilitates Innate Immune Evasion of Liver Cancer. Advanced Science. 12(45). e09989–e09989. 1 indexed citations

Jiang, Jun, Jianpeng Xiao, Liang Shi, et al.. (2023). Exploring the boost of steaming with wine on Ligustri Lucidi Fructus in treating postmenopausal osteoporosis based on superior “multi-component structure” and iron/bone metabolism coregulation. Phytomedicine. 123. 155275–155275. 2 indexed citations

Zhang, Peng, Yaxin Wang, Yuping Yin, et al.. (2022). 4-Octyl itaconate regulates immune balance by activating Nrf2 and negatively regulating PD-L1 in a mouse model of sepsis. International Journal of Biological Sciences. 18(16). 6189–6209. 36 indexed citations

Sun, Hongwei, Shanshan Zhang, Yilin Zhou, et al.. (2021). An immunogenomic signature for molecular classification in hepatocellular carcinoma. Molecular Therapy — Nucleic Acids. 25. 105–115. 40 indexed citations

Fan, Run, Yufan Chen, Sarah Nechuta, et al.. (2021). Prediction models for breast cancer prognosis among Asian women. Cancer. 127(11). 1758–1769. 8 indexed citations

Shi, Liang, Shaobo Zhang, Zhenlin Huang, et al.. (2020). Baicalin promotes liver regeneration after acetaminophen-induced liver injury by inducing NLRP3 inflammasome activation. Free Radical Biology and Medicine. 160. 163–177. 63 indexed citations

Zhang, Peng, Yuping Yin, Tao Wang, et al.. (2019). Maresin 1 mitigates concanavalin A-induced acute liver injury in mice by inhibiting ROS-mediated activation of NF-κB signaling. Free Radical Biology and Medicine. 147. 23–36. 60 indexed citations

Wang, Shuyang, Alicia Beeghly‐Fadiel, Qiuyin Cai, et al.. (2018). Gene expression in triple-negative breast cancer in relation to survival. Breast Cancer Research and Treatment. 171(1). 199–207. 33 indexed citations

Sheng, Yuchen, et al.. (2017). Long-term acetaminophen treatment induced liver fibrosis in mice and the involvement of Egr-1. Toxicology. 382. 47–58. 36 indexed citations

10.

Shi, Liang, Hui Lin, Gonghui Li, et al.. (2016). Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression. Molecular Cancer Therapeutics. 15(4). 731–742. 46 indexed citations

11.

Shi, Liang, Yuchen Sheng, Zhiyong Zheng, et al.. (2016). Caffeic acid attenuated acetaminophen-induced hepatotoxicity by inhibiting ERK1/2-mediated early growth response-1 transcriptional activation. Chemico-Biological Interactions. 260. 186–195. 24 indexed citations

12.

Wang, Xuefeng, Jun Wang, Yong Liang, et al.. (2016). Schistosoma japonicum HSP60-derived peptide SJMHE1 suppresses delayed-type hypersensitivity in a murine model. Parasites & Vectors. 9(1). 147–147. 16 indexed citations

13.

Xu, Junjie, Hui Lin, Gonghui Li, et al.. (2016). The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals. EBioMedicine. 12. 55–67. 65 indexed citations

14.

Shi, Liang, Li Wu, Zhanguo Chen, et al.. (2015). MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil. Cellular Physiology and Biochemistry. 35(6). 2333–2348. 114 indexed citations

15.

Shi, Liang, Zhanguo Chen, Lili Wu, et al.. (2015). miR-340 Reverses Cisplatin Resistance of Hepatocellular Carcinoma Cell Lines by Targeting Nrf2-dependent Antioxidant Pathway. Asian Pacific Journal of Cancer Prevention. 15(23). 10439–10444. 80 indexed citations

16.

Shi, Liang, et al.. (2014). Inhibitory effect of gallic acid and its oxidation products on CYP3A in rat liver microsomes.. Di-Si Junyi Daxue xuebao. 36(2). 130–134. 1 indexed citations

17.

Zhang, Jiaqi, et al.. (2014). Therapeutic detoxification of quercetin against carbon tetrachloride-induced acute liver injury in mice and its mechanism. Journal of Zhejiang University SCIENCE B. 15(12). 1039–1047. 49 indexed citations

18.

Li, Rui, Liang Shi, Jian Jia, et al.. (2012). Differentiating the Associations of Waist Circumference and Body Mass Index With Cardiovascular Disease Risk in a Chinese Population. Asia Pacific Journal of Public Health. 27(2). NP457–NP467. 10 indexed citations

19.

Chen, Hao, Liang Shi, Xiaoyang Yang, et al.. (2010). Artesunate inhibiting angiogenesis induced by human myeloma RPMI8226 cells. International Journal of Hematology. 92(4). 587–597. 39 indexed citations

20.

Ferraris, Dana, Mark Ginski, Liang Shi, et al.. (2003). Design and synthesis of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. part 4: Biological evaluation of imidazobenzodiazepines as potent PARP-1 inhibitors for treatment of ischemic injuries. Bioorganic & Medicinal Chemistry. 11(17). 3695–3707. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact